Starting your patients on Fanapt®

Fanapt® patients can safely reach an efficacious dose in as few as 5 days1
Dosing chart
  • Fanapt® can be administered without regard to meals

 

Dosing chart

 

Consider metabolic pathways

Dosing chart
  • Dose should be reduced by half when administered concomitantly with strong CYP2D6 inhibitors.
  • When the CYP2D6 or CYP3A4 inhibitors are withdrawn from the combination therapy, Fanapt® dose should be increased to where it was before.

 

Fanapt® significantly improved overall bipolar I disorder symptoms.1,2
Find out more
References: 1. Fanapt® package insert. Washington, DC: Vanda Pharmaceuticals Inc.; 04/2024. 2. Torres R, Czeisler EL, Chadwick SR, et al. Efficacy and safety of iloperidone in bipolar mania: a double-blind, placebo-controlled study. J Clin Psychiatry. 2024;85(1):23m14966